C. Neuratris and E. , This work was supported by France Parkinson (NCT02319382)

C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, Mechanisms underlying inflammation in neurodegeneration, Cell, vol.140, pp.918-934, 2010.

S. Venneti, B. J. Lopresti, and C. A. Wiley, The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging, Prog Neurobiol, vol.80, pp.308-322, 2006.

A. Varrone, P. Mattsson, and A. Forsberg, In vivo imaging of the 18-kDa translocator protein (TSPO) with [ 18 F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients, Eur J Nucl Med Mol Imaging, vol.40, pp.921-931, 2013.

Y. Fujimura, S. S. Zoghbi, and F. G. Simeon, Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, 18 F-PBR06, J Nucl Med, vol.50, pp.1047-1053, 2009.

Q. Guo, A. Colasanti, and D. R. Owen, Quantification of the specific translocator protein signal of 18 F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding, J Nucl Med, vol.54, pp.1915-1923, 2013.

P. M. Rusjan, A. A. Wilson, and P. M. Bloomfield, Quantitation of translocator protein binding in human brain with the novel radioligand [ 18 F]-FEPPA and positron emission tomography, J Cereb Blood Flow Metab, vol.31, pp.1807-1816, 2011.

H. Boutin, C. Prenant, and R. Maroy, in a model of cerebral ischemia in rats, PLoS ONE, vol.8, p.56441, 2013.

F. Chauveau, N. Van-camp, and F. Dolle, Comparative evaluation of the translocator protein radioligands 11 C-DPA-713, 18 F-DPA-714, and 11 C-PK11195 in a rat model of acute neuroinflammation, J Nucl Med, vol.50, pp.468-476, 2009.

S. Lavisse, M. Guillermier, and A. S. Herard, Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J Neurosci, vol.32, pp.10809-10818, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02110993

N. Arlicot, J. Vercouillie, and M. J. Ribeiro, Initial evaluation in healthy humans of [ 18 F]DPA-714, a potential PET biomarker for neuroinflammation, Nucl Med Biol, vol.39, pp.570-578, 2012.

P. Corcia, C. Tauber, and J. Vercoullie, Molecular imaging of microglial activation in amyotrophic lateral sclerosis, PLoS ONE, vol.7, p.52941, 2012.

S. S. Golla, R. Boellaard, and V. Oikonen, Quantification of [F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients, J Cereb Blood Flow Metab, vol.35, pp.766-772, 2015.

M. J. Ribeiro, J. Vercouillie, and S. Debiais, Could (18) F-DPA-714 PET imaging be interesting to use in the early post-stroke period?, EJNMMI Res, vol.4, pp.28-35, 2014.

D. R. Owen, O. W. Howell, and S. P. Tang, Two binding sites for [ 3 H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation, J Cereb Blood Flow Metab, vol.30, pp.1608-1618, 2010.

D. R. Owen, Q. Guo, and N. J. Kalk, Determination of [ 11 C]PBR28 binding potential in vivo: a first human TSPO blocking study, J Cereb Blood Flow Metab, vol.34, pp.989-994, 2014.

R. B. Innis, V. J. Cunningham, and J. Delforge, Consensus nomenclature for in vivo imaging of reversibly binding radioligands, J Cereb Blood Flow Metab, vol.27, pp.1533-1539, 2007.

C. J. Endres, M. G. Pomper, and M. James, Initial evaluation of 11 C-DPA-713, a novel TSPO PET ligand, in humans, J Nucl Med, vol.50, pp.1276-1282, 2009.

F. E. Turkheimer, P. Edison, and N. Pavese, Reference and target region modeling of [ 11 C]-(R)-PK11195 brain studies, J Nucl Med, vol.48, pp.158-167, 2007.

J. M. Coughlin, Y. Wang, and S. Ma, Regional brain distribution of translocator protein using [ 11 C]DPA-713 PET in individuals infected with HIV, J Neurovirol, vol.20, pp.219-232, 2014.

D. R. Owen, R. N. Gunn, and E. A. Rabiner, Mixed-affinity binding in humans with 18-kDa translocator protein ligands, J Nucl Med, vol.52, pp.24-32, 2011.

I. Suridjan, P. M. Rusjan, and A. N. Voineskos, Neuroinflammation in healthy aging: a PET study using a novel translocator protein 18kDa (TSPO) radioligand, Neuroimage, vol.84, pp.868-875, 2014.

R. Mizrahi, P. M. Rusjan, and J. Kennedy, Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [ 18 F]-FEPPA, J Cereb Blood Flow Metab, vol.32, pp.968-972, 2012.

M. A. Peyronneau, W. Saba, and S. Goutal, Metabolism and quantification of [ 18 F] DPA-714, a new TSPO positron emission tomography radioligand, Drug Metab Dispos, vol.41, pp.122-131, 2013.


, J Nucl Med

C. Comtat, P. Remy, B. Stankoff, M. Lavisse, D. García-lorenzo et al.,

, Information about reproducing figures, tables, or other portions of this article can be found online at